Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1

Yang Yu1, Qiaoyu Chen2, Xunlei Zhang1

  • 1Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong, China.

Cancer Science
|May 8, 2020
PubMed

Insights

The long noncoding RNA ANRIL promotes cholangiocarcinoma (CCA) by epigenetically silencing the tumor suppressor ERRFI1. Inhibiting ANRIL suppressed CCA cell growth and migration, suggesting ANRIL as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • Long noncoding RNAs (lncRNAs) play crucial roles in human cancers.
  • The lncRNA ANRIL's function in cholangiocarcinoma (CCA) is currently unknown.

Purpose of the Study:

  • To investigate the role of ANRIL in cholangiocarcinoma (CCA) development.
  • To explore ANRIL's potential as a therapeutic target for CCA.

Main Methods:

  • RNA sequencing analysis was performed after ANRIL knockdown.
  • The interaction between ANRIL, EZH2, and the ERRFI1 promoter was investigated.
  • Cell proliferation and migration assays were conducted in vitro and in vivo.

Main Results:

  • ANRIL knockdown significantly inhibited CCA cell proliferation and migration.
  • ANRIL epigenetically suppresses the tumor suppressor gene ERRFI1 by interacting with EZH2 and maintaining H3K27me3 levels.
  • RNA sequencing revealed ANRIL knockdown altered genes involved in cell cycle, proliferation, and apoptosis.

Conclusions:

  • ANRIL acts as an oncogenic molecule in CCA through epigenetic regulation.
  • ANRIL is a potential therapeutic target for cholangiocarcinoma intervention.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.1K